Skip to main content

Raiffeisen Bank International AG

Bank

Position in ABBV — AbbVie Inc.

CIK 2044885 VIENNA, C4

Position in ABBV

as of Jun 30, 2026 · filed Aug 3, 2026
Position Value
$95,605,836
+$15,106,263 QoQ
Shares Held
379,931
+2.6% QoQ
Ownership
0.022%
of shares outstanding
% of Portfolio
1.12%
of 13F equity value
Holder Rank
#261
of 4,153 holders
Holding Since
Dec 2024
7 quarters on record
Voting authority Sole 94% Shared 0% None 6%

Common Shares in ABBV Over Time

Shares Held

Position Value (USD)

Derivatives in ABBV

reported options exposure · as of Jun 30, 2026
CallValue
$1,509
CallShares
6
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Drug Manufacturers - General

Healthcare · as of Jun 30, 2026

Raiffeisen Bank International AG holds $427,125,963 across 9 Drug Manufacturers - General names. ABBV ranks #2 (22.4% of the industry book) .

# Ticker Company Shares Value (USD) Open
2 ABBV
AbbVie Inc.
This page
379,931 $95,605,836

All Filings in ABBV

Export CSV
11 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $1,509 6
2026-06-30 $95,605,836 379,931
2026-03-31 $1,304 6
2026-03-31 $80,499,573 370,130
2025-12-31 $70,080,624 306,712
2025-12-31 $1,370 6
2025-09-30 $72,072,150 311,273
2025-09-30 $1,389 6
2025-06-30 $59,566,014 320,903
2025-03-31 $71,112,345 339,406
2024-12-31 $62,951,113 354,255